期刊文献+

吡喹酮水凝胶栓剂在家兔体内的药动学研究 被引量:13

Pharmacokinetics of praziquantel liquid suppository in rabbits
暂未订购
导出
摘要 目的研究吡喹酮水凝胶栓剂经直肠给药后在家兔体内的药动学及相对生物利用度。方法取家兔12只,随机分为口服给药组和直肠给药组二组,给药后采用HPLC法测定血药浓度。结果经3p97药动学程序处理吡喹酮水凝胶栓剂经直肠给药的药-时数据符合一房室开放药代动力学模型,其相对生物利用度为173.2%。结论吡喹酮水凝胶栓剂的生物利用度是口服给药的1.7倍,具有一定的开发价值。 Objective To study the pharmacokinetics and bioavailability of praziquantcl liquid suppository in rabbits. Method A single dose of praziquantel was orally and rectally administrated to 12 rabbits in an open randomized crossover test. HPLC was selected to determine the concentration of praziquantel in plasma. Result The pharmacokinetic parameters of praziquantel were obtained by3p97 program and best described by a one-compartment model. Relative bioavailability of praziquantel was 173.2%. Conclusion The praziquantel liquid suppository has higher bioavilability than praziquantel solution in rabbits.
作者 申献玲 张洪
出处 《广东药学院学报》 CAS 2006年第1期25-26,31,共3页 Academic Journal of Guangdong College of Pharmacy
关键词 吡喹酮水凝胶栓剂 高效液相色谱法 药动学 生物利用度 praziquantel liquid suppository HPLC pharmacokinetics bioavailability
  • 相关文献

参考文献7

二级参考文献20

  • 1靳和国,胡佳文,吴晓华.泊洛沙姆在扑热息痛片中的应用[J].中国医药工业杂志,1995,26(4):157-158. 被引量:3
  • 2郑俊民 逢秀娟 王星.葛根大豆甙与泊洛沙姆共沉淀物的研究[J].沈阳药学院学报,1987,4(2):89-92.
  • 3Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine[J]. Trends Biotechnol, 2000,18: 412-420.
  • 4Olbrich C, Muiler RH. Enzymetic degradation of SLN-effect of surfactant and surfactant mixtures[J].Int J Pharm, 1999,180:31-39.
  • 5Redhead HM, Davis SS, Ilium L. Drug delivery in poly(lactide-co-glycolide)nanoparticles surface modified with poloxamer 407 and poloxamer 908:in vitro characterization and in vivo evaluation [J]. J Controlled Release, 2001,70 : 353-363.
  • 6Yun MO,Choi HG, Jung JH,et al. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement[J]. Int J pharm, 1999,189:137-145.
  • 7Chi HG. , Lee MK, Kim MH, et al. Effect of additives on the physicochemical properties of liquid suppository bases[J]. Int J Pharm, 1999,190:13-19.
  • 8Morikawa K, Okada F, Hosokawa M, et al. Enhancement of therapeutic effects of recombinant interleukin-2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, Pluronic gel [J]. Cancer, 1987,47: 37-41.
  • 9Fults KA, Johnston TP. Sustained-release of urease from a poloxamer gel matrix [J] J Parenter Sci Technl, 1990,44(2): 58-65.
  • 10Katakam M,Ravis WR, Banga AK. Controlled release of human growth hormone in rats following parenteral administration of Poloxamer gels [J]. J Controlled Release, 1997,49(1 ): 21-26.

共引文献48

同被引文献179

引证文献13

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部